Evidence map›Paper›PMID 38588052›Full record

ArticleBrain : a journal of neurology2024

More than 185 CAG repeats: a point of no return in Huntington's disease biology.

Jillian Belgrad, Anastasia Khvorova

Abstract readEditorialComment
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jillian BelgradRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-2577-2336
Anastasia KhvorovaRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0001-6928-8071

Funding

Expanding the chemical diversity of therapeutic oligonucleotides to treat neurodegenerative disordersR01NS104022 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ANASTASIA KHVOROVA · 2017 to 2026
$6.0M
Modulation of Somatic Repeat Expansion as a Therapeutic Approach to Huntington's DiseaseF31NS132424 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BELGRAD, JILLIAN · 2023 to 2025
$72k
NIH HHS R01 NS104022NINDS NIH HHS F31 NS132424NINDS NIH HHS R01 NS104022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Huntington DiseaseHumansHuntingtin ProteinTrinucleotide Repeat ExpansionTrinucleotide RepeatsHTT protein, humanHuntingtin Protein

Identifiers

PMID38588052
PMCPMC11068098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.